Chitosan-pectin multiparticulate systems associated with enteric polymers for colonic drug delivery

[1]  H. R. Salgado,et al.  Alginate-chitosan systems: In vitro controlled release of triamcinolone and in vivo gastrointestinal transit , 2010 .

[2]  R. C. Evangelista,et al.  In vitro characterization of coevaporates containing chitosan for colonic drug delivery , 2009 .

[3]  G. Cheng,et al.  Wax-Matrix Tablet for Time-Dependent Colon-Specific Delivery System of Sophora Flavescens Aiton: Preparation and In Vivo Evaluation , 2009, Drug development and industrial pharmacy.

[4]  Wei Zhang,et al.  Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. , 2009, Colloids and surfaces. B, Biointerfaces.

[5]  W. Xie,et al.  Characterization and biodegradation of chitosan-alginate polyelectrolyte complexes , 2009 .

[6]  B. Luppi,et al.  Pectin-based microspheres for colon-specific delivery of vancomycin. , 2009, The Journal of pharmacy and pharmacology.

[7]  P. Mura,et al.  Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  M. Repka,et al.  In‐vivo evaluation in rats of colon‐specific microspheres containing 5‐fluorouracil , 2008, The Journal of pharmacy and pharmacology.

[9]  K. Goracinova,et al.  Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  H. Onishi,et al.  Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. , 2008, International journal of pharmaceutics.

[11]  A. Kraneveld,et al.  Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. , 2007, Pharmacology & therapeutics.

[12]  R. Tharanathan,et al.  Chitin/chitosan: modifications and their unlimited application potential—an overview , 2007 .

[13]  A. R. Kulkarni,et al.  Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. , 2007, International journal of pharmaceutics.

[14]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[15]  R. C. Evangelista,et al.  Studies on the formation of complex coacervates between chitosan and alginate during microparticles preparation , 2005 .

[16]  D. Friend.  New oral delivery systems for treatment of inflammatory bowel disease. , 2005, Advanced drug delivery reviews.

[17]  Joseph Kost,et al.  Pectin-based systems for colon-specific drug delivery via oral route. , 2003, Biomaterials.

[18]  D. Durand,et al.  Influence of pH, Ca concentration, temperature and amidation on the gelation of low methoxyl pectin , 2003 .

[19]  Mansoor Amiji,et al.  Chitosan-based gastrointestinal delivery systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[20]  R. C. Evangelista,et al.  Microspheres of alginate-chitosan containing isoniazid. , 2003, Journal of microencapsulation.

[21]  T. Vandamme,et al.  The use of polysaccharides to target drugs to the colon , 2002 .

[22]  Libo Yang,et al.  Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. , 2002, International journal of pharmaceutics.

[23]  V. Sinha,et al.  Polysaccharides in colon-specific drug delivery. , 2001, International journal of pharmaceutics.

[24]  K.L.B. Chang,et al.  Swelling behavior and the release of protein from chitosan–pectin composite particles , 2000 .

[25]  S. A. Sande,et al.  Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  A. Bernkop‐Schnürch.  Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. , 2000, International journal of pharmaceutics.

[27]  T. Fujita,et al.  Colon-specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules , 2000 .

[28]  C. Leopold,et al.  Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD). , 1998, Journal of drug targeting.

[29]  J. Fell,et al.  Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release , 1997 .

[30]  T. Barber.  Pharmaceutical Particulate Matter: Analysis and Control , 1993 .